Document is current

Any future updates will be listed below

Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection

Crossref DOI link: https://doi.org/10.1007/s00408-024-00781-4

Published Online: 2025-01-06

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark